[Successful treatment of Bowen disease with ingenol mebutate]

S A Braun; B Homey; P A Gerber

doi:10.1007/s00105-014-3509-5

[Successful treatment of Bowen disease with ingenol mebutate]

Hautarzt. 2014 Oct;65(10):848-50. doi: 10.1007/s00105-014-3509-5.

[Article in German]

Authors

S A Braun¹, B Homey, P A Gerber

Affiliation

¹ Hautklinik des Universitätsklinikums Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.

PMID: 25217087
DOI: 10.1007/s00105-014-3509-5

Abstract

Ingenol mebutate is a novel cytotoxic drug extracted from the plant Euphorbia peplus. Since November 2012 it is approved in Germany for the treatment of superficial actinic keratoses. We report the successful treatment of Bowen disease with ingenol mebutate in a patient being treated with the multikinase inhibitor sunitinib for to metastatic clear cell renal carcinoma.

Publication types

Case Reports
English Abstract

MeSH terms

Aged
Antineoplastic Agents / administration & dosage
Bowen's Disease / drug therapy*
Bowen's Disease / pathology*
Diterpenes / administration & dosage*
Humans
Male
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology*

Substances

3-ingenyl angelate
Antineoplastic Agents
Diterpenes